Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143987 |
| CAS No | NA |
| Mol.F. | C5H6N2O4 |
| Mol.Wt. | 158.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143988 |
| CAS No | NA |
| Mol.F. | C6H11N3O5 |
| Mol.Wt. | 205.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143989 |
| CAS No | NA |
| Mol.F. | C5H8N2O2 |
| Mol.Wt. | 128.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143990 |
| CAS No | NA |
| Mol.F. | C6H11ClN2O2 |
| Mol.Wt. | 178.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143991 |
| CAS No | NA |
| Mol.F. | C9H17N3O2 |
| Mol.Wt. | 199.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143992 |
| CAS No | NA |
| Mol.F. | C9H16N4O3 |
| Mol.Wt. | 228.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143993 |
| CAS No | NA |
| Mol.F. | C6H13N3O4S |
| Mol.Wt. | 223.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143994 |
| CAS No | NA |
| Mol.F. | C14H12N2O4 |
| Mol.Wt. | 272.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143995 |
| CAS No | 58858-73-4 |
| Mol.F. | C6H6ClN3O |
| Mol.Wt. | 171.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143996 |
| CAS No | NA |
| Mol.F. | C14H12N2O4 |
| Mol.Wt. | 272.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143997 |
| CAS No | NA |
| Mol.F. | C19H21N3O2 |
| Mol.Wt. | 323.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143998 |
| CAS No | NA |
| Mol.F. | C9H16N4O3Si |
| Mol.Wt. | 256.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143999 |
| CAS No | NA |
| Mol.F. | C7H9N3O |
| Mol.Wt. | 151.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144000 |
| CAS No | 149573-80-8 |
| Mol.F. | C5H6N4O3 |
| Mol.Wt. | 170.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144001 |
| CAS No | NA |
| Mol.F. | C7H10ClN5O2 |
| Mol.Wt. | 231.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144002 |
| CAS No | NA |
| Mol.F. | C29H23Cl2N3O8S |
| Mol.Wt. | 644.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |